Both proteins might be involved in the molecular mechanism of colon carcinoma. As a result, the increase in METRNL and Asprosin in colon carcinoma suggests that these proteins may be therapeutic targets in the diagnosis and treatment of colon carcinoma, one of the most common cancers. This evidence concerns the gene METRNL and colon carcinoma.